Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Apply
Opevesostat vs. NHA
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step